Home > Qtrly Results > INDO US BIOTECH

INDO US BIOTECH
Quarterly Results Analysis [Dec2025]

AD     Remove this Ad

INDO US BIOTECH Quarterly Results

Standalone Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
Audited
Revenues ₹23 Cr ₹31 Cr ₹31 Cr ₹33 Cr ₹24 Cr ₹22 Cr ₹25 Cr ₹16 Cr
Expenses ₹19 Cr ₹27 Cr ₹25 Cr ₹29 Cr ₹18 Cr ₹17 Cr ₹21 Cr ₹15 Cr
Operating Income ₹4 Cr ₹4 Cr ₹5 Cr ₹5 Cr ₹6 Cr ₹5 Cr ₹4 Cr ₹1 Cr
Other Income ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Profit Before Tax ₹3 Cr ₹4 Cr ₹5 Cr ₹4 Cr ₹5 Cr ₹4 Cr ₹3 Cr ₹1 Cr
Profit After Tax ₹3 Cr ₹3 Cr ₹5 Cr ₹4 Cr ₹5 Cr ₹4 Cr ₹3 Cr ₹1 Cr
EPS ₹1.49 ₹1.72 ₹2.35 ₹1.84 ₹2.52 ₹2.17 ₹1.58 ₹0.26
Industry Peers & Returns1W1M1Y
INDO US BIOTECH 0.7% 4.9% -42.8%
BOMBAY BURMAH TRADING CORPORATION 3.5% -6.6% -17.7%
KAVERI SEED COMPANY -1.5% -5.3% -7.2%
VENKYS (INDIA) 5.7% 2.2% -12.9%
BOMBAY SUPER HYBRID SEEDS 3.9% -12.4% -44.7%
MANGALAM GLOBAL ENTERPRISE 5.7% -11.2% -6.9%
HARRISONS MALAYALAM -2.7% -5.2% -32.1%
TIERRA AGROTECH -2.9% -9% -8.4%
NATH BIOGENES (INDIA) 2.5% -2.1% -10.9%

INDO US BIOTECH Quarterly Revenues

Revenues
Q-o-Q

-26.09 %

Y-o-Y

-3.25 %

Quarters Revenues % Change
Dec2025 ₹23 Cr
-26.09
Sep2025 ₹31 Cr
0.25
Jun2025 ₹31 Cr
-7.83
Mar2025 ₹33 Cr
41.68
Dec2024 ₹24 Cr
6.27
Sep2024 ₹22 Cr
-10.30
Jun2024 ₹25 Cr
56.78
Mar2024 ₹16 Cr -

INDO US BIOTECH Quarterly Operating Profit

Operating Profit
Q-o-Q

-0.29 %

Y-o-Y

-25.09 %

Quarters Operating Profit % Change
Dec2025 ₹4 Cr
-0.29
Sep2025 ₹4 Cr
-23.91
Jun2025 ₹5 Cr
19.38
Mar2025 ₹5 Cr
-17.29
Dec2024 ₹6 Cr
8.18
Sep2024 ₹5 Cr
38.77
Jun2024 ₹4 Cr
280.52
Mar2024 ₹1 Cr -
Operating Margins
Q-o-Q

34.89 %

Y-o-Y

-22.54 %

Quarters Operating Margin% % Change
Dec2025 18.21%
34.89
Sep2025 13.5%
-24.07
Jun2025 17.78%
29.50
Mar2025 13.73%
-41.60
Dec2024 23.51%
1.77
Sep2024 23.1%
54.72
Jun2024 14.93%
142.76
Mar2024 6.15% -

INDO US BIOTECH Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-13.18 %

Y-o-Y

-40.71 %

Quarters Profit After Tax % Change
Dec2025 ₹3 Cr
-13.18
Sep2025 ₹3 Cr
-26.60
Jun2025 ₹5 Cr
27.63
Mar2025 ₹4 Cr
-27.10
Dec2024 ₹5 Cr
15.94
Sep2024 ₹4 Cr
37.58
Jun2024 ₹3 Cr
504.77
Mar2024 ₹1 Cr -
PAT Margins
Q-o-Q

17.52 %

Y-o-Y

-38.69 %

Quarters PAT Margin(%) % Change
Dec2025 13.15 %
17.52
Sep2025 11.19 %
-26.77
Jun2025 15.28 %
38.41
Mar2025 11.04 %
-48.53
Dec2024 21.45 %
9.10
Sep2024 19.66 %
53.35
Jun2024 12.82 %
286.14
Mar2024 3.32 % -

INDO US BIOTECH Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-13.37 %

Y-o-Y

-40.87 %

Quarters EPS % Change
Dec2025 ₹1.49
-13.37
Sep2025 ₹1.72
-26.81
Jun2025 ₹2.35
27.72
Mar2025 ₹1.84
-26.98
Dec2024 ₹2.52
16.13
Sep2024 ₹2.17
37.34
Jun2024 ₹1.58
507.69
Mar2024 ₹0.26 -

You may also like the below Video Courses